Regulation of the Renal Microcirculation by the Connecting Tubule

连接小管对肾脏微循环的调节

基本信息

  • 批准号:
    7580940
  • 负责人:
  • 金额:
    $ 32.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-07 至 2012-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In hypertension the pressure natriuresis set point is shifted to a higher pressure, due to an increase in both renal vascular resistance and Na+ reabsorption. The afferent arterioles (Af-Art) and efferent arterioles account for most renal vascular resistance; they control glomerular filtration rate (GFR) and peritubular pressure, and consequently renal function. Af-Art resistance is regulated by factors similar to those that control other arterioles; in addition, the Af-Art is also controlled by tubuloglomerular feedback (TGF). TGF operates via the macula densa, which senses increases in NaCl and sends a signal that constricts the Af-Art. We have evidence that increasing NaCl delivery to the connecting tubule (CNT) dilates the Af-Art, and that this dilatation can be blocked by inhibitors of Na+ transport. We refer to the cross-talk between the CNT and Af-Art as connecting tubule glomerular feedback (CTGF). Here we propose to study CTGF both in vitro and in vivo to determine its physiological role and the mechanisms by which Na+ causes CTGF. We will also study the regulation of CTGF by nitric oxide (NO) and the tubular renin-angiotensin system (RAS), since both NO synthase and renin and angiotensinogen are expressed in the nephron. In vitro and in vivo we propose to test the general hypothesis that Na+ reabsorption by the connecting tubule induces the release of arachidonic acid metabolites that diffuse to and promote dilatation of the Af-Art (CTGF response). Thus CTGF antagonizes vasoconstrictor stimuli such as TGF. The tubular RAS potentiates CTGF by stimulating Na+ transport by the CNT, while NO blunts CTGF by inhibiting this process. We will test this general hypothesis in four Aims. Aim I will test whether an increase in Na+ reabsorption in the CNT causes an increase in intracellular Ca++ via the Na+/ Ca++ exchanger, which results in Ca++-mediated activation of phospholipases, release of arachidonic acid, and formation of eicosanoids which diffuse to the Af-Art and cause dilatation. Aim II will test whether in vivo, CTGF opposes the vasoconstrictor effect of TGF and whether in the absence of TGF, CTGF causes Af-Art dilatation. Aim III will test whether NO produced by NOS 3 in the CNT decreases CTGF by blocking Na+ transport by ENaC via activation of guanylyl cyclase, increasing cGMP, activating cGMP-dependent protein kinase, and reducing cAMP. Aim IV will test whether the tubular RAS via Ang II and the AT1 receptor enhances CTGF directly by acting on ENaC and indirectly by stimulating the release of O2- via NADPH oxidase. This will be the first study to determine the role of the renal connecting tubule in the regulation of afferent arteriole resistance and glomerular filtration rate. This is a novel mechanism that will provide new insights on the regulation of renal function.
描述(由申请人提供):在高血压中,由于肾血管阻力和Na+再吸收的增加,压力钠尿设定点转移到更高的压力。肾血管阻力主要由传入小动脉和传出小动脉引起;它们控制肾小球滤过率(GFR)和小管周围压力,从而控制肾功能。Af-Art抵抗是由与控制其他小动脉相似的因素调节的;此外,Af-Art还受管肾小球反馈(TGF)的控制。TGF通过黄斑致密组织起作用,黄斑致密组织感知到NaCl的增加,并发出信号收缩Af-Art。我们有证据表明,增加连接小管(CNT)的NaCl递送会使Af-Art扩张,并且这种扩张可以被Na+运输抑制剂阻断。我们将CNT和Af-Art之间的串扰称为连接小管肾小球反馈(CTGF)。我们拟对CTGF进行体内外两方面的研究,以确定其生理作用及Na+引起CTGF的机制。我们还将研究一氧化氮(NO)和管状肾素-血管紧张素系统(RAS)对CTGF的调控,因为NO合酶和肾素和血管紧张素原都在肾单位中表达。在体外和体内,我们提出验证连接小管的Na+重吸收诱导花生四烯酸代谢物的释放,这些代谢物扩散到Af-Art并促进其扩张(CTGF反应)的一般假设。因此,CTGF拮抗血管收缩刺激如TGF。管状RAS通过刺激CNT的Na+转运来增强CTGF,而NO通过抑制这一过程来减弱CTGF。我们将用四个目标来检验这个一般假设。目的I将测试CNT中Na+重吸收的增加是否会通过Na+/ Ca++交换器导致细胞内Ca++的增加,从而导致Ca++介导的磷脂酶激活,花生四烯酸的释放,以及扩散到Af-Art并引起扩张的二十烷类化合物的形成。Aim II将检测体内CTGF是否对抗TGF的血管收缩作用,以及在TGF不存在的情况下,CTGF是否引起Af-Art扩张。Aim III将测试CNT中NOS 3产生的NO是否通过阻断ENaC通过guany酰环化酶的转运、增加cGMP、激活cGMP依赖性蛋白激酶和降低cAMP来降低CTGF。Aim IV将测试管状RAS是否通过Ang II和AT1受体直接作用于ENaC,间接通过NADPH氧化酶刺激O2-的释放来增强CTGF。这将是首次确定肾连接小管在调节传入小动脉阻力和肾小球滤过率中的作用的研究。这是一种新的机制,将为肾功能调节提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oscar A. Carretero其他文献

Ren-2 Gene Salt Hypertensive Mice Lacking − Antagonist in Deoxycorticosterone Acetate Effects of Angiotensin-converting Enzyme Inhibitor and Angiotensin Type 1 Receptor
Ren-2基因盐高血压小鼠缺乏-醋酸脱氧皮质酮拮抗剂对血管紧张素转换酶抑制剂和血管紧张素1型受体的影响
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hongmei Peng;Oscar A. Carretero;M. Alfie;Julie A. Masura;N. Rhaleb
  • 通讯作者:
    N. Rhaleb
Cross-talk between arterioles and tubules in the kidney
  • DOI:
    10.1007/s00467-008-0852-8
  • 发表时间:
    2009-01-01
  • 期刊:
  • 影响因子:
    2.600
  • 作者:
    YiLin Ren;Jeffrey L. Garvin;Ruisheng Liu;Oscar A. Carretero
  • 通讯作者:
    Oscar A. Carretero
Effects of propranolol on the development of renovascular hypertension in the rat
  • DOI:
    10.1016/s0002-8703(77)80347-5
  • 发表时间:
    1977-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Andreas P. Niarchos;Om P. Gulati;Oscar A. Carretero
  • 通讯作者:
    Oscar A. Carretero
Urinary kallikrein and plasma renin during the reversal of renovascular hypertension in rats.
大鼠肾血管性高血压逆转过程中的尿激肽释放酶和血浆肾素。
Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.
激肽介导雷米普利在大鼠颈动脉中的抗增殖作用。

Oscar A. Carretero的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oscar A. Carretero', 18)}}的其他基金

Tubuloglomerular Feedback Regulation by Carbon Monoxide
一氧化碳的肾小球反馈调节
  • 批准号:
    8376983
  • 财政年份:
    2012
  • 资助金额:
    $ 32.63万
  • 项目类别:
Regulation of renal Microcirulation
肾脏微循环的调节
  • 批准号:
    7595340
  • 财政年份:
    2009
  • 资助金额:
    $ 32.63万
  • 项目类别:
Regulation of the Renal Microcirculation by the Connecting Tubule
连接小管对肾脏微循环的调节
  • 批准号:
    8034726
  • 财政年份:
    2008
  • 资助金额:
    $ 32.63万
  • 项目类别:
Regulation of the Renal Microcirculation by the Connecting Tubule
连接小管对肾脏微循环的调节
  • 批准号:
    7356857
  • 财政年份:
    2008
  • 资助金额:
    $ 32.63万
  • 项目类别:
Regulation of the Renal Microcirculation by the Connecting Tubule
连接小管对肾脏微循环的调节
  • 批准号:
    7766928
  • 财政年份:
    2008
  • 资助金额:
    $ 32.63万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7249774
  • 财政年份:
    2007
  • 资助金额:
    $ 32.63万
  • 项目类别:
Ang II-Induced Hypertension: Role of Ac-SDKP in End Organ Damage
Ang II 诱发的高血压:Ac-SDKP 在终末器官损伤中的作用
  • 批准号:
    7249766
  • 财政年份:
    2007
  • 资助金额:
    $ 32.63万
  • 项目类别:
Regulation of Renal Microcirculation in Ang II-Induced Hypertension
血管紧张素II诱发高血压肾微循环的调节
  • 批准号:
    7249769
  • 财政年份:
    2007
  • 资助金额:
    $ 32.63万
  • 项目类别:
AUTOCRINE/PARACRINE REGULATION OF RENAL MICROCIRCULATION
肾微循环的自分泌/旁分泌调节
  • 批准号:
    6649479
  • 财政年份:
    2002
  • 资助金额:
    $ 32.63万
  • 项目类别:
Ac-SDKP in target organ damage in hypertension
Ac-SDKP 在高血压靶器官损伤中的作用
  • 批准号:
    6649484
  • 财政年份:
    2002
  • 资助金额:
    $ 32.63万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 32.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 32.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了